Elastic liposomes mediated transcutaneous immunization against Hepatitis B Fulltext Access 9 Pages 2006
Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-γ production in BALB/c mice infected with Mycobacterium avium Fulltext Access 9 Pages 2006
A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents Fulltext Access 9 Pages 2006
Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates Fulltext Access 9 Pages 2006
Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice Fulltext Access 9 Pages 2006
Immunogenicity of CTLA4 fusion anti-caries DNA vaccine in rabbits and monkeys Fulltext Access 9 Pages 2006
Factors influencing MMR vaccination decisions following a mumps outbreak on a university campus Fulltext Access 9 Pages 2006
Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis Fulltext Access 9 Pages 2006
Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles Fulltext Access 9 Pages 2006
Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse Fulltext Access 9 Pages 2006
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines Fulltext Access 9 Pages 2006
Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization Fulltext Access 9 Pages 2006
Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis Fulltext Access 9 Pages 2006
Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide Fulltext Access 9 Pages 2006
Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants Fulltext Access 9 Pages 2006
Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice Fulltext Access 9 Pages 2006
Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects Fulltext Access 9 Pages 2006
A vaccine against the salmonid pathogen Piscirickettsia salmonis based on recombinant proteins Fulltext Access 9 Pages 2006
Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques Fulltext Access 9 Pages 2006
Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR649–684, a mucosal subunit HIV/AIDS vaccine candidate Fulltext Access 9 Pages 2006
The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease Fulltext Access 9 Pages 2006
Intramuscular immunization with a DNA vaccine encoding a 26-amino acid CETP epitope displayed by HBc protein and containing CpG DNA inhibits atherosclerosis in a rabbit model of atherosclerosis Fulltext Access 9 Pages 2006
Analysis of costimulatory molecule expression on antigen-specific T and B cells during the induction of adjuvant-induced Th1 and Th2 type responses Fulltext Access 9 Pages 2006
Dissecting the components of the humoral immune response elicited by DNA vaccines Fulltext Access 9 Pages 2006
Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin Fulltext Access 9 Pages 2006
Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine Fulltext Access 9 Pages 2006
Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania major Fulltext Access 9 Pages 2006
Enhancement of functional antibody responses to AMA1-C1/Alhydrogel®, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide Fulltext Access 9 Pages 2006
Vaccination with a preparation based on recombinant cysteine peptidases and canine IL-12 does not protect dogs from infection with Leishmania infantum Fulltext Access 9 Pages 2006
Sculpting the immunological response to dengue fever by polytopic vaccination Fulltext Access 9 Pages 2006
Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams Fulltext Access 9 Pages 2006
CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope Fulltext Access 9 Pages 2006
Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component Fulltext Access 9 Pages 2006
Jaagsiekte sheep retrovirus-specific immune responses induced by vaccination: A comparison of immunisation strategies Fulltext Access 9 Pages 2006
Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses Fulltext Access 9 Pages 2006
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers Fulltext Access 9 Pages 2006
Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine Fulltext Access 9 Pages 2006
Vaccination with IFN-inducible T cell α chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells Fulltext Access 9 Pages 2006
Stable episomal expression system under control of a stress inducible promoter enhances the immunogenicity of Bacillus subtilis as a vector for antigen delivery Fulltext Access 9 Pages 2006
Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide Fulltext Access 9 Pages 2006
Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin Fulltext Access 9 Pages 2006
Nonclinical toxicology study of recombinant-plasmid DNA anti-rabies vaccines Fulltext Access 9 Pages 2006
Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine Fulltext Access 9 Pages 2006
Vaccination of mice against intestinal Trichinella spiralis infections by oral administration of antigens microencapsulated in methacrilic acid copolymers Fulltext Access 9 Pages 2006
Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines Fulltext Access 9 Pages 2006
Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV) Fulltext Access 9 Pages 2006
Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli Fulltext Access 9 Pages 2006
Characterization of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9) Fulltext Access 9 Pages 2006
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge Fulltext Access 9 Pages 2006
DNA vaccination of macaques by a full-genome SHIV plasmid that has an IL-2 gene and produces non-infectious virus particles Fulltext Access 9 Pages 2006
Transcriptional analysis of protective antigen-stimulated PBMC from non-human primates vaccinated with the anthrax vaccine absorbed Fulltext Access 9 Pages 2006
Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production Fulltext Access 9 Pages 2006
Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations Fulltext Access 9 Pages 2006
Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation Fulltext Access 9 Pages 2006
The jejunal Peyer's patches are the major inductive sites of the F4-specific immune response following intestinal immunisation of pigs with F4 (K88) fimbriae Fulltext Access 9 Pages 2006
Costs of congenital rubella syndrome (CRS) in Oman: Evidence based on long-term follow-up of 43 children Fulltext Access 9 Pages 2006
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers Fulltext Access 9 Pages 2006
Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice Fulltext Access 9 Pages 2006
Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA) Fulltext Access 9 Pages 2006
Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein Fulltext Access 9 Pages 2006
Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever Fulltext Access 9 Pages 2006
The rabies peripheral challenge test: More accurate determination of vaccine potency Fulltext Access 9 Pages 2006
Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media Fulltext Access 9 Pages 2006
The cost-effectiveness of alternative polio immunization policies in South Africa Fulltext Access 9 Pages 2006
Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system Fulltext Access 9 Pages 2006
Maintenance of CD8 effector T cells by CD4 helper T cells eradicates growing tumors and promotes long-term tumor immunity Fulltext Access 9 Pages 2006
A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide Fulltext Access 9 Pages 2006
The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age Fulltext Access 9 Pages 2006
Immunogenicity and safety of a combined DTaP–IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4–6 years Fulltext Access 9 Pages 2006
A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4–6 years Fulltext Access 9 Pages 2006
Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice Fulltext Access 9 Pages 2006
Analysis of a delayed epidemic model with pulse vaccination and saturation incidence Fulltext Access 9 Pages 2006
N-fragment of edema factor as a candidate antigen for immunization against anthrax Fulltext Access 9 Pages 2006
Hydrophobic moeties in recombinant proteins are crucial to generate efficient saponin-based vaccine against Apicomplexan Babesia divergens Fulltext Access 9 Pages 2006
l-Arginine stimulates immune response in chickens immunized with intermediate plus strain of infectious bursal disease vaccine Fulltext Access 9 Pages 2006
Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides Fulltext Access 9 Pages 2006
Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12 Fulltext Access 9 Pages 2006
A novel DNA vaccine encoding PDGFRβ suppresses growth and dissemination of murine colon, lung and breast carcinoma Fulltext Access 9 Pages 2006
Influence of the nature of the antigen on the boosting of responses to mycobacteria in M. bovis-BCG vaccinated cattle Fulltext Access 9 Pages 2006
Safety and efficacy of an infectious bronchitis virus used for chicken embryo vaccination Fulltext Access 9 Pages 2006
Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant Fulltext Access 9 Pages 2006
Development of canine herpesvirus based antifertility vaccines for foxes using bacterial artificial chromosomes Fulltext Access 9 Pages 2006
Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice Fulltext Access 9 Pages 2006
The immunogenicity and protective efficacy of Mtb8.4/hIL-12 chimeric gene vaccine Fulltext Access 9 Pages 2006
Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization Fulltext Access 9 Pages 2006
Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant Fulltext Access 9 Pages 2006
Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist Fulltext Access 9 Pages 2006
Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs Fulltext Access 9 Pages 2006
Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients Fulltext Access 9 Pages 2006
Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity Fulltext Access 9 Pages 2006
Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2 Fulltext Access 9 Pages 2006